#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cervix carcinoma Alagille syndrome Crigler-Najjar syndrome Leukaemia Familial haemophagocytic lymphohistiocytosis Synovitis Soft tissue sarcoma Idiopathic intracranial hypertension Vulval cancer recurrent Encephalopathy neonatal Colorectal adenocarcinoma Skin cancer Peritoneal neoplasm General anaesthesia Inclusion body myositis More trials…

    Learn about Rare Diseases

    Leiomyosarcoma metastatic – Treatment Mantle cell lymphoma – Life with Disease Biotinidase deficiency – Diagnostics Mucopolysaccharidosis II – Treatment Extranodal marginal zone B-cell lymphoma (MALT type) – Basic Information Angelman’s syndrome – Life with Disease Mastocytosis – Treatment Congenital hypotransferrinaemia – Diagnostics Waldenstrom’s macroglobulinaemia refractory – Diagnostics Indolent systemic mastocytosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Heparin Calcium Mps-103 Travoprost Tadalafil Lorlatinib Plasma Tub-040 Ieramilimab [89ZR]ZR-DFO-CIT-013 Timolol VMX-C001 Oxymetazoline Hydrochloride Tavapadon Citalopram Hydrochloride ICOTROKINRA Dasiglucagon Simvastatin Mps-102 Lapatinib Tiemonium Methylsulphate More therapies…

    Learn about Your Condition

    Anal squamous cell carcinoma Angiosarcoma recurrent Haemoptysis Neuromuscular scoliosis Oropharyngeal cancer recurrent Chondroplasty Traumatic pain Medication overuse headache Mucopolysaccharidosis Iron deficiency Relapsing multiple sclerosis Mitral valve incompetence Hypertrophic cardiomyopathy Oedema peripheral Thromboangiitis obliterans More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hepatitis D

  • A study comparing brelovitug to bulevirtide for treating chronic hepatitis delta infection in patients currently receiving bulevirtide

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Hepatitis D
    Investigated Drugs:
    • Bjt-778
    • Bulevirtide
    Austria Czechia France Germany Italy Romania +1

  • Study of GS-4321 for Healthy People and Patients With Chronic Hepatitis Delta Virus Infection

    Recruiting

    2 1
    Investigated Diseases:
    • Hepatitis D
    Investigated Drugs:
    • GS-4321
    Bulgaria Germany Italy Romania

  • Clinical Trial for Patients with Chronic Hepatitis D: Comparing Brelovitug and Bulevirtide Treatments

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Bjt-778
    • Bulevirtide
    Austria Czechia France Germany Italy Romania +2

  • Study on the Effects and Safety of Bulevirtide, Peginterferon Alfa-2a, and Entecavir in Patients with Chronic Hepatitis D

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatitis D
    Investigated Drugs:
    • Peginterferon Alfa-2A
    • Bulevirtide
    • Entecavir
    Sweden

  • A Study of Brelovitug Compared to Delayed Treatment in Patients with Chronic Hepatitis Delta Infection

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Bjt-778
    Belgium Bulgaria Hungary

  • Study on BJT-778 for Patients with Chronic Hepatitis Delta Infection

    Not recruiting

    4 1 1
    Investigated Drugs:
    • Bjt-778
    Bulgaria
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!